Stock Movers: Expedia, Akam, Monster Beverage (Podcast)

Expedia reported Q1 revenue of $3.43 billion, up 15% year over year and above the $3.35 billion consensus, but left full-year guidance unchanged; it also forecast Q2 revenue of $4.11 billion to $4.19 billion and shares fell. Akami Technologies surged after announcing a leading frontier AI model provider committed $1.8 billion over seven years for its Cloud Infrastructure Services, alongside first-quarter results and outlook. Monster Beverage gained after first-quarter adjusted EPS beat estimates and JPMorgan raised its price target.

Analysis

AKAM is the cleanest structural winner here: the contract size implies a step-up in revenue visibility that can re-rate the name if management can prove this is the first of several AI infrastructure wins rather than a one-off. The market is likely underappreciating operating leverage from high-retention, usage-based infrastructure deals; if the customer expands workloads, the earnings power inflects over a 12-24 month window with limited incremental capex intensity versus building proprietary capacity. The read-through is negative for smaller CDN/security peers that compete on enterprise spend but lack a differentiated AI compute adjacency.

EXPE looks like a classic ‘good quarter, disappointing setup’ reaction. Leaving the full-year view unchanged after a strong quarter signals either conservatism or uncertainty about the second half, which matters because travel demand is highly elastic to FX, airfare, and corporate budgets. The World Cup demand tailwind is real but time-bounded; the bigger issue is whether hotel and airline partners have already priced in peak event demand, which can cap upside in the next 1-2 quarters and leave the stock vulnerable if consumer spend normalizes.

MNST’s move is more about sentiment than fundamentals: a modest earnings beat plus a target hike can extend a relief rally, but this is still a category where volume growth and mix matter more than headline EPS. The market is likely missing that beverages with premium price points are more exposed to consumer trade-down than the current tape suggests; if mass-market disposable income softens, outperformance can fade quickly. JPM is a secondary beneficiary only insofar as the target hike supports the narrative that staples still have pricing power, but that is usually a short-lived catalyst.

Key Decisions for Investors

• Long AKAM on pullbacks over the next 3-10 trading days; target a 6-10% squeeze if the market starts pricing multi-year AI infrastructure optionality, with a tight stop if the deal is framed as non-recurring.
• Pair trade: long AKAM / short a basket of slower-growing edge/security peers over 1-3 months to express relative AI infrastructure monetization, since AKAM now has a clearer catalyst path and better contract visibility.
• Fade EXPE strength with a short or put spread into the next 4-8 weeks if the stock rallies on the unchanged guide; the risk/reward favors downside if investors conclude second-half acceleration is already embedded.
• Stay neutral-to-underweight MNST after the initial pop; use strength to sell covered calls or trim longs, since the catalyst is likely priced in and consumer-demand deceleration would hit the name over the next 1-2 quarters.
• Avoid chasing JPM on the target hike alone; if anything, use it as a read-through that analyst sentiment is lagging price action and is not a high-conviction incremental signal.